GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Book Value per Share

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Book Value per Share : ₦7.71 (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Book Value per Share?

GlaxoSmithKline Consumer Nigeria's book value per share for the quarter that ended in Jun. 2023 was ₦7.71.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Book Value Per Share Growth Rate was -2.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 18.40% per year. The lowest was -19.00% per year. And the median was 1.70% per year.

GlaxoSmithKline Consumer Nigeria's current price is ₦17.00. Its book value per share for the quarter that ended in Jun. 2023 was ₦7.71. Hence, today's PB Ratio of GlaxoSmithKline Consumer Nigeria is 2.21.

During the past 13 years, the highest P/B Ratio of GlaxoSmithKline Consumer Nigeria was 5.52. The lowest was 0.45. And the median was 1.48.


GlaxoSmithKline Consumer Nigeria Book Value per Share Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Book Value per Share Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.39 7.65 7.63 7.78 7.97

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.94 7.62 7.73 7.97 7.71

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Book Value per Share

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's PB Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's PB Ratio falls into.



GlaxoSmithKline Consumer Nigeria Book Value per Share Calculation

GlaxoSmithKline Consumer Nigeria's Book Value Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(9,532-0)/1,196
=7.97

GlaxoSmithKline Consumer Nigeria's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(9,214-0)/1,196
=7.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


GlaxoSmithKline Consumer Nigeria Book Value per Share Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines